-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Alaunos Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2025.
- Alaunos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 2.18M shares, a 36.3% increase year-over-year.
- Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1.6M shares, a 0.11% increase from 2023.
- Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.6M shares, a 89% decline from 2022.
- Alaunos Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 14.5M shares, a 93.2% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)